351 related articles for article (PubMed ID: 29559282)
1. Risk of Late Urinary Complications Following Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: Refining Bladder Dose-Volume Parameters.
Manea E; Escande A; Bockel S; Khettab M; Dumas I; Lazarescu I; Fumagalli I; Morice P; Deutsch E; Haie-Meder C; Chargari C
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):411-420. PubMed ID: 29559282
[TBL] [Abstract][Full Text] [Related]
2. Intermediate dose-volume parameters and the development of late rectal toxicity after MRI-guided brachytherapy for locally advanced cervix cancer.
Ujaimi R; Milosevic M; Fyles A; Beiki-Ardakani A; Carlone M; Jiang H; Lindsay P; Xie J; Gerber R; Croke J; Skliarenko J; Levin W; Han K
Brachytherapy; 2017; 16(5):968-975.e2. PubMed ID: 28757404
[TBL] [Abstract][Full Text] [Related]
3. Bladder accumulated dose in image-guided high-dose-rate brachytherapy for locally advanced cervical cancer and its relation to urinary toxicity.
Zakariaee R; Hamarneh G; Brown CJ; Gaudet M; Aquino-Parsons C; Spadinger I
Phys Med Biol; 2016 Dec; 61(24):8408-8424. PubMed ID: 27845913
[TBL] [Abstract][Full Text] [Related]
4. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
[TBL] [Abstract][Full Text] [Related]
5. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
6. MRI-guided brachytherapy in locally advanced cervical cancer: Small bowel [Formula: see text] and [Formula: see text] are not predictive of late morbidity.
Petit C; Dumas I; Chargari C; Martinetti F; Maroun P; Doyeux K; Tailleur A; Haie-Meder C; Mazeron R
Brachytherapy; 2016; 15(4):463-470. PubMed ID: 27180130
[TBL] [Abstract][Full Text] [Related]
7. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
[TBL] [Abstract][Full Text] [Related]
8. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
[TBL] [Abstract][Full Text] [Related]
9. Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience.
Mahantshetty U; Swamidas J; Khanna N; Engineer R; Merchant NH; Deshpande DD; Shrivastava S
Int J Gynecol Cancer; 2011 Aug; 21(6):1110-6. PubMed ID: 21633296
[TBL] [Abstract][Full Text] [Related]
10. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
Lee LJ; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
[TBL] [Abstract][Full Text] [Related]
11. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factors.
Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
[TBL] [Abstract][Full Text] [Related]
12. Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: Dose-volume effect relationships for the rectum and bladder.
Mazeron R; Maroun P; Castelnau-Marchand P; Dumas I; del Campo ER; Cao K; Slocker-Escarpa A; M'Bagui R; Martinetti F; Tailleur A; Guemnie-Tafo A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
Radiother Oncol; 2015 Aug; 116(2):226-32. PubMed ID: 26164773
[TBL] [Abstract][Full Text] [Related]
13. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
14. Assessment of dose to functional sub-structures in the lower urinary tract in locally advanced cervical cancer radiotherapy.
Spampinato S; Fokdal L; Marinovskij E; Axelsen S; Pedersen EM; Pötter R; Lindegaard JC; Tanderup K
Phys Med; 2019 Mar; 59():127-132. PubMed ID: 30772142
[TBL] [Abstract][Full Text] [Related]
15. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study.
Mazeron R; Fokdal LU; Kirchheiner K; Georg P; Jastaniyah N; Šegedin B; Mahantshetty U; Hoskin P; Jürgenliemk-Schulz I; Kirisits C; Lindegaard JC; Dörr W; Haie-Meder C; Tanderup K; Pötter R;
Radiother Oncol; 2016 Sep; 120(3):412-419. PubMed ID: 27396811
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience.
Simha V; Rai B; Patel FD; Kapoor R; Sharma SC; Singh OA; Singla V; Dhanireddy B; Ghoshal S
Brachytherapy; 2018; 17(2):345-351. PubMed ID: 29102740
[TBL] [Abstract][Full Text] [Related]
17. Late side effects of 3T MRI-guided 3D high-dose rate brachytherapy of cervical cancer : Institutional experiences.
Vojtíšek R; Sukovská E; Baxa J; Budíková M; Kovářová P; Fínek J
Strahlenther Onkol; 2019 Nov; 195(11):972-981. PubMed ID: 31309266
[TBL] [Abstract][Full Text] [Related]
18. Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer.
Kim Y; Kim YJ; Kim JY; Lim YK; Jeong C; Jeong J; Kim M; Lim MC; Seo SS; Park SY
Brachytherapy; 2017; 16(1):116-125. PubMed ID: 27876378
[TBL] [Abstract][Full Text] [Related]
19. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
Hung J; Shen S; De Los Santos JF; Kim RY
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
[TBL] [Abstract][Full Text] [Related]
20. Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer.
Fokdal L; Pötter R; Kirchheiner K; Lindegaard JC; Jensen NBK; Kirisits C; Chargari C; Mahantshetty U; Jürgenliemk-Schulz IM; Segedin B; Hoskin P; Tanderup K
Radiother Oncol; 2018 Jun; 127(3):423-430. PubMed ID: 29784450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]